Interesting ImagesPancreatic Schwannoma on FDG PET/CTWang, Xuezhu MD∗; Lv, Jingqiao BA∗; Fu, Chao BA∗; Chang, Xiaoyan MD, PhD†; Huo, Li MD, PhD∗Author Information From the ∗Department of Nuclear Medicine and Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine †Department of Pathology, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and PUMC, Beijing, China. Received for publication June 16, 2020; revision accepted June 19, 2020. Conflicts of interest and sources of funding: This work was sponsored in part by the National Natural Science Foundation of China (grant 81571713), CAMS Innovation Fund for Medical Sciences (CIFMS)(grant 2016-37 I2M-4-003), and CAMS initiative for innovative medicine (grant CAMS-2018-I2M-3-001). None declared for all authors. Correspondence to: Li Huo, MD, PhD, Department of Nuclear Medicine, Peking Union Medical College Hospital, 1# Shuaifuyuan, Dongcheng District, Beijing, China 100730. E-mail: [email protected]. Clinical Nuclear Medicine: November 2020 - Volume 45 - Issue 11 - p 921-922 doi: 10.1097/RLU.0000000000003229 Buy Metrics Abstract A 55-year-old woman underwent FDG PET/CT to evaluate a pancreatic mass. The images showed elevated FDG activity in the uncinated process of the pancreas, suggestive of malignancy. However, pathological examination from the resected lesion demonstrated pancreatic schwannoma. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.